EDGAR Filing Documents for 0001532176-17-000017

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001532176-17-000017

Filing Date

2017-05-04

Accepted

2017-05-04 07:43:33

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	regn-033117x10q.htm	10-Q	1442631
2	CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)	regn-ex_311x03312017x10q.htm	EX-31.1	16762
3	CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)	regn-ex_312x03312017x10q.htm	EX-31.2	16758
4	CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350	regn-ex_32x03312017x10q.htm	EX-32	8076
	Complete submission text file	0001532176-17-000017.txt		5938848

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	regn-20170331.xml	EX-101.INS	1114199
6	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	regn-20170331.xsd	EX-101.SCH	41536
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	regn-20170331_cal.xml	EX-101.CAL	73553
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	regn-20170331_def.xml	EX-101.DEF	309796
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	regn-20170331_lab.xml	EX-101.LAB	552554
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	regn-20170331_pre.xml	EX-101.PRE	353271

Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591

Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9143477000

REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)